Showing results (91-100 of 120) with videos related to
Sort By:
Pageof 12
Current Opinion in Pulmonary Medicine|October 5, 2001
Orally active heparin and low-molecular-weight heparinG F Pineo, R D Hull, V J MarderArchives of Internal Medicine|January 8, 1996
Cost-effectiveness of pulmonary embolism diagnosisR D Hull, W Feldstein, P D Stein, et al.Chest|May 1, 1993
Strategy for diagnosis of patients with suspected acute pulmonary embolismP D Stein, R D Hull, H A Saltzman, et al.Annals of Internal Medicine|December 29, 1998
Drug-induced thrombocytopenia: a systematic review of published case reportsJ N George, G E Raskob, S R Shah, et al.Canadian Medical Association Journal|November 15, 1982
Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patientsR D Hull, J Hirsh, D L Sackett, et al.The Journal of Bone and Joint Surgery. British Volume|February 11, 2012
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trialsG E Raskob, A S Gallus, G F Pineo, et al.American Industrial Hygiene Association Journal|July 1, 1980
A comparison of four personal sampling methods for the determination of mercury vaporC S McCammon, S L Edwards, R D Hull, et al.Journal of Medicinal Chemistry|May 4, 2001
Mining the chemical quarry with joint chemical probes: an application of latent semantic structure indexing (LaSSI) and TOPOSIM (Dice) to chemical database miningS B Singh, R P Sheridan, E M Fluder, et al.Journal of Thrombosis and Haemostasis : JTH|January 3, 2013
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroupsG F Pineo, A S Gallus, G E Raskob, et al.Journal of Thrombosis and Haemostasis : JTH|September 27, 2015
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trialG Agnelli, H R Buller, A Cohen, et al.Pageof 12